Download PDF
1 / Pages

Other users also viewed these articles

Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023 Carlos Abud-Mendoza; Francisco Javier Aceves-Ávila; César Alejandro Arce-Salinas; José Álvarez Nemegyei; Leonor Barile-Fabris; Sergio Durán-Barragán; Diana Elsa Flores-Alvarado; Eufrates Hernández-Núñez; Fedra Irazoque-Palazuelos; José Francisco Moctezuma-Ríos; Virginia Pascual-Ramos; Margarita Portela-Hernández; Luis Humberto Silveira; Lilia Andrade-Ortega; Ana Barrera-Vargas; Sandra Carrillo-Vázquez; Zully Castro-Colin; Enrique Cuevas-Orta; Luis Felipe Flores-Suárez; Guillermo Arturo Guaracha-Basáñez; María Fernanda Hernández-Cabrera; Iván de Jesús Hernández-Galarza; David Alejandro Herrera-vanOostdam; Adriana Concepción Lobato-Belmonte; Laura Aline Martínez-Martínez; Marco Ulises Martínez-Martínez; Gabriel Medrano-Ramírez; Francisco Javier Merayo-Chalico; Graciela Meza-López y Olguín; Francisco Olan; Genaro Peña-Santos; César Ramos-Remus; Greta Reyes-Cordero; Vijaya Rivera-Terán; Jorge Rojas-Serrano; Griselda Serna-Peña; Sandra Sicsik-Ayala; César Armando Sifuentes-Cantú; David Vega-Morales; Pablo Villaseñor-Ovies; Daniel Xibillé-Friedmann; César Pacheco-Tena;
Reumatol Clin. 2024;20:263-80
Safety and effectiveness of bDMARDs during pregnancy in patients with rheumatic diseases: Real-world data from the BIOBADASER registry Cristina Membrive-Jiménez; Carlos Sánchez-Piedra; Olga Martínez-González; Javier García-González; Lorena Expósito-Pérez; Cristina Bohórquez-Heras; Cristina Campos-Fernández; Fernando Sanchez-Alonso; Rafael Cáliz-Cáliz; Isabel Castrejón-Fernández;
Reumatol Clin. 2023;19:500-6
Disease control in patients with psoriatic arthritis in real clinical practice in Spain: MiDAS study Jordi Gratacós; José L. Pablos; Eugenio de Miguel; Xavier Juanola; Cristina Fernández-Carballido; Rafael Ariza; Pau Terradas-Montana; Carlos Sastré; Cristina Sanabra;
Reumatol Clin. 2023;19:204-10